49
Anti-Pseudoscience Advocate Anne Borden King Has Cancer, and Now Her Facebook Feed Is Full of Pseudoscience Cancer ‘Alternative Care’ Ads

Anne Borden King, writing at The New York Times:

Last week, I posted about my breast cancer diagnosis on Facebook. Since then, my Facebook feed has featured ads for “alternative cancer care.” The ads, which were new to my timeline, promote everything from cumin seeds to colloidal silver as cancer treatments. Some ads promise luxury clinics — or even “nontoxic cancer therapies” on a beach in Mexico.

There’s a reason I’ll never fall for these ads: I’m an advocate against pseudoscience. As a consultant for the watchdog group Bad Science Watch and the founder of the Campaign Against Phony Autism Cures, I’ve learned to recognize the hallmarks of pseudoscience marketing: unproven and sometimes dangerous treatments, promising simplistic solutions and support. Things like “bleach cures” that promise to treat everything from Covid-19 to autism.

When I saw the ads, I knew that Facebook had probably tagged me to receive them. Interestingly, I haven’t seen any legitimate cancer care ads in my newsfeed, just pseudoscience. This may be because pseudoscience companies rely on social media in a way that other forms of health care don’t.

“May be” is too kind, as is “social media” in general as opposed to Facebook in particular. Scammers and fraudsters of all sorts, from alternative “medicine” quacks to financial investment grifters, have found a welcoming home advertising and promoting their rackets on Facebook.

They don’t advertise on legitimate media because legitimate media won’t have them, and because Facebook makes it affordable by doing all the hard work of targeting for them. Facebook is a criminal enterprise fully and knowingly complicit in all of this — from the spread of bigotry to the spread of pseudoscience.

Conversely, legitimate advertisers are abandoning Facebook because they want nothing to do with any of this. To remain on Facebook is to be complicit by association.

Monday, 13 July 2020